Skip to main content

Iran approves second Iranian-made COVID-19 vaccine

Iran's vaccine rollout has been marked by delays as the virus continues to spread rapidly across the country.
An Iranian health worker prepares an injection of the Iranian-made COVID-19 vaccine during the start of the second phase of trials in the capital, Tehran, on March 15, 2021.

Iran’s Health Ministry has approved a second domestically made COVID-19 vaccine for emergency use. The vaccine campaign in Iran has been relatively slow, and the country has been badly hit by the coronavirus. 

Iranian Health Minister Saeid Namaki said Tuesday that the Pasteur vaccine completed its third phase of clinical trials and received “permission for its emergency use.” The vaccine was developed in partnership with Cuban scientists, the state-owned Press TV reported.

Access the Middle East news and analysis you can trust

Join our community of Middle East readers to experience all of Al-Monitor, including 24/7 news, analyses, memos, reports and newsletters.


Only $100 per year.